Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 273

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 273
---
 the Iris Board (separate and apart from the Charter Proposal). In the judgment of the special committee and the Iris Board, these provisions are necessary to adequately address the needs of the Combined Company. Furthermore, the Business Combination is not conditioned on the separate approval of the Advisory Charter Proposals.

Iris stockholders will be asked to approve, on a non-binding advisory basis, the following material differences between the Proposed ParentCo Certificate of Incorporation and the Iris Certificate of Incorporation, which are being presented as six separate sub-proposals (the “Advisory Charter Proposals”):

(1)

Advisory Charter Proposal A — to amend the name of the public entity to “Liminatus Pharma, Inc.” from “Iris Acquisition Corp”;

(2)

Advisory Charter Proposal B — to authorize the issuance of up to 500,000,000 shares of common stock, and up to 1,000,000 shares of “blank check” preferred stock, the rights, preferences and privileges of which may be designated from time to time by Liminatus’s board of directors;

(3)

Advisory Charter Proposal C — to provide that the removal of any director be only for cause and by the affirmative vote of at least 66 2 ∕ 3 % of Liminatus’s then-outstanding shares of capital stock entitled to vote generally in the election of directors;

(4)

Advisory Charter Proposal D — to make Liminatus’s corporate existence perpetual as opposed to Iris’s corporate existence, which is required to be dissolved and liquidated 36 months following the closing of its initial public offering if it does not complete a business combination in that time, and to remove from the Proposed ParentCo Certificate of Incorporation the various provisions applicable only to special purpose acquisition corporations;

(5)

Advisory Charter Proposal E — to provide that Liminatus will not be subject to Section 203 of the DGCL; and

(6)

Advisory Charter Proposal F — to increase the required vote thresholds for approving amendments to the Proposed ParentCo Certificate of Incorporation and bylaws to 66 2 ∕ 3 %.

#### Reasons for the Advisory Charter Amendments
In the judgment of the Iris Board, the advisory amendments to the Iris Certificate of Incorporation are desirable for the following reasons:

•

the name of the new public entity is desirable to reflect the Business Combination with Liminatus and the combined business going forward;

•

the greater number of authorized number of shares of capital stock is desirable